NAMPT inhibition uncovers therapeutic vulnerabilities to venetoclax and chemotherapy in acute myelogenous leukemia
Year: 2025
Type: article
Language: en
Topic: Sirtuins and Resveratrol in Medicine
Authors and affiliations:
raw_author_name: John R. Sanchez
raw_affiliation_strings: Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center
Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
raw_author_name: Chaomei Liu
raw_affiliation_strings: Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center
Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
raw_author_name: Vishakha Pawar
raw_affiliation_strings: Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center
Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
raw_author_name: Yanqing Huang
raw_affiliation_strings: Evolution of Cancer, Leukemia, and Immunity Post Stem Cell Transplant (ECLIPSE), The University of Texas M.D. Anderson Cancer Center
Evolution of Cancer, Leukemia, and Immunity Post Stem Cell Transplant (ECLIPSE), The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
raw_author_name: Daisy Diaz-Rohena
raw_affiliation_strings: Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center
Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
raw_author_name: Jyotsana Singh
raw_affiliation_strings: Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center
Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
raw_author_name: Priya Koppikar
raw_affiliation_strings: Evolution of Cancer, Leukemia, and Immunity Post Stem Cell Transplant (ECLIPSE), The University of Texas M.D. Anderson Cancer Center
Evolution of Cancer, Leukemia, and Immunity Post Stem Cell Transplant (ECLIPSE), The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
raw_author_name: Tzung-Huei Lai
raw_affiliation_strings: Division of Hematology, Department of Internal Medicine, The Ohio State University
Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA
raw_author_name: Lisa St. John
raw_affiliation_strings: Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center
Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
raw_author_name: Vinay Puduvalli
raw_affiliation_strings: Department of Neuro-oncology, The University of Texas M.D. Anderson Cancer Center
Department of Neuro-oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
raw_author_name: Jeffrey Molldrem
raw_affiliation_strings: Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center
Evolution of Cancer, Leukemia, and Immunity Post Stem Cell Transplant (ECLIPSE), The University of Texas M.D. Anderson Cancer Center
Evolution of Cancer, Leukemia, and Immunity Post Stem Cell Transplant (ECLIPSE), The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
raw_author_name: Palaniraja Thandapani
raw_affiliation_strings: Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center
Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
raw_author_name: Nitin Jain
raw_affiliation_strings: Department of Leukemia, The University of Texas M.D. Anderson Cancer Center
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
raw_author_name: Rosa Lapalombella
raw_affiliation_strings: Division of Hematology, Department of Internal Medicine, The Ohio State University
Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH, USA
raw_author_name: Deepa Sampath
raw_affiliation_strings: Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center
Department of Hematopoietic Biology and Malignancy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA